Related references
Note: Only part of the references are listed.Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study
Maria Cristina Vedovati et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Chromogenic anti-FXa assay calibrated with low molecular weight heparin in patients treated with rivaroxaban and apixaban: possibilities and limitations
Sandra Margetic et al.
BIOCHEMIA MEDICA (2020)
Real-time detection and differentiation of direct oral anticoagulants (rivaroxaban and dabigatran) using modified thromboelastometric reagents
Simon Thomas Schafer et al.
THROMBOSIS RESEARCH (2020)
Detecting Anti-IIa and Anti-Xa Direct Oral Anticoagulant (DOAC) Agents in Urine using a DOAC Dipstick
Job Harenberg et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
Rapid point-of-care detection and classification of direct-acting oral anticoagulants with the TEG 6s: Implications for trauma and acute care surgery
Joao D. Dias et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2019)
Modified ROTEM for the detection of rivaroxaban and apixaban anticoagulant activity in whole blood A diagnostic test study
Claire Pailleret et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2019)
Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
Janja Pretnar Oblak et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2019)
Fully automated thromboelastograph TEG 6s to measure anticoagulant effects of direct oral anticoagulants in healthy male volunteers
Ramin Artang et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2019)
Impact of four direct oral anticoagulants on rotational thromboelastometry (ROTEM)
L. Seyve et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2018)
Direct oral anticoagulants: When to consider laboratory testing?
H. ten Cate et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2018)
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants
Robert C. Gosselin et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis
Matthias Ebner et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation
Yvonne M. C. Henskens et al.
THROMBOSIS JOURNAL (2018)
Point-of-Care Coagulation Tests Monitoring of Direct Oral Anticoagulants and Their Reversal Therapy: State of the Art
Giacomo E. Iapichino et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)
Impact of rivaroxaban on point-of-care assays
Pierre Fontana et al.
THROMBOSIS RESEARCH (2017)
Whole blood coagulation assays ROTEM and T-TAS to monitor dabigatran treatment
Viktor Taune et al.
THROMBOSIS RESEARCH (2017)
In vitro and ex vivo Measurement of Prophylactic Dabigatran Concentrations with a New Ecarin-Based Thromboelastometry Test
Mareike Kristina Koerber et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2017)
Assessment of Haemostasis in patients undergoing emergent neurosurgery by rotational Elastometry and standard coagulation tests: a prospective observational study
Christoph Ellenberger et al.
BMC ANESTHESIOLOGY (2017)
Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants
Bethany T. Samuelson et al.
CHEST (2017)
Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants
Hugo ten Cate et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2017)
A Case of Fatal Bleeding Following Emergency Surgery on an Ascending Aorta Intramural Hematoma in a Patient Taking Dabigatran
Giulia Beatrice Crapelli et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2016)
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Rivaroxaban and intracranial haemorrhage after mild traumatic brain injury: A dangerous combination?
Christopher Beynon et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2015)
Development of cryopelletization and formulation measures to improve stability of Echis carinatus venum protein for use in diagnostic rotational thromboelastometry
Matthias Erber et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Production and Characterization of Rapidly Dissolving Cryopellets
Matthias Erber et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Detection of acute traumatic coagulopathy and massive transfusion requirements by means of rotational thromboelastometry: an international prospective validation study
Jostein S. Hagemo et al.
CRITICAL CARE (2015)
Dabigatran anticoagulation and Stanford type A aortic dissection: lethal coincidence
P. Stein et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2014)
TEG and ROTEM: Technology and clinical applications
David Whiting et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Measuring the activity of apixaban and rivaroxaban with rotational thrombelastometry
Dieter Adelmann et al.
THROMBOSIS RESEARCH (2014)
Dabigatran etixilate and traumatic brain injury: Evolving anticoagulants require evolving care plans
Sam Pakraftar et al.
WORLD JOURNAL OF CLINICAL CASES (2014)
Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx
Daniel Chappell et al.
CRITICAL CARE (2014)
Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives
Guy Young et al.
BLOOD (2013)
Fast interpretation of thromboelastometry in non-cardiac surgery: reliability in patients with hypo-, normo-, and hypercoagulability
K. Goerlinger et al.
BRITISH JOURNAL OF ANAESTHESIA (2013)
Rotational thrombolelastometry produces potentially clinical useful results within 10 min in bleeding Emergency Department patients: the DEUCE study
Matthew J. Reed et al.
EUROPEAN JOURNAL OF EMERGENCY MEDICINE (2013)
Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants
D. Garcia et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Ecarin modified rotational thrombelastometry: a point-of-care applicable alternative to monitor the direct thrombin inhibitor argatroban
Eva Schaden et al.
WIENER KLINISCHE WOCHENSCHRIFT (2013)
Accurate determination of rivaroxaban levels requires different calibrator sets but not addition of antithrombin
Helen Mani et al.
THROMBOSIS AND HAEMOSTASIS (2012)
FIBTEM provides early prediction of massive transfusion in trauma
Herbert Schoechl et al.
CRITICAL CARE (2011)
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: A pooled analysis of three trials
R. J. Friedman et al.
THROMBOSIS RESEARCH (2010)
Rotational thrombelastometry for the bedside monitoring of recombinant hirudin
C. Sucker et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2008)
Low plasma fibrinogen levels with the Clauss method during anticoagulation with bivalirudin
Ross J. Molinaro et al.
ANESTHESIOLOGY (2008)
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty
Bengt I. Eriksson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty
Michael R. Lassen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement:: a randomised, double-blind, non-inferiority trial
Bengt I. Eriksson et al.
LANCET (2007)
Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation
B Sorensen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Share Paper
